Bikaji Foods International Limited (BOM:543653)

Inozyme Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	2,191	86.54	168.12	25.05	17.59
Short-Term Investments	-	359.95	1,274	1,285	1,239	919.49
Cash & Short-Term Investments	2,550	2,550	1,361	1,453	1,264	937.08
Cash Growth	43.78%	87.43%	-6.35%	14.93%	34.92%	-6.48%
Accounts Receivable	-	1,009	1,035	792.04	733.06	473.09
Other Receivables	-	-	606.23	54.22	152.95	63.14
Receivables	-	1,022	1,642	846.26	899.19	548.45
Inventory	-	1,079	821.42	784.2	728.92	567.68
Prepaid Expenses	-	-	22.72	23.54	35.36	11.99
Restricted Cash	-	-	-	-	-	4.36
Other Current Assets	-	2,801	1,116	1,082	497.46	288.29
Total Current Assets	-	7,453	4,963	4,189	3,425	2,358
Property, Plant & Equipment	-	9,828	8,131	7,245	5,554	4,530
Long-Term Investments	-	393.58	894.24	499.79	1,358	687.98
Goodwill	-	303.76	37.71	-	-	-
Other Intangible Assets	-	627.78	12.74	8.5	11.59	19.01
Long-Term Deferred Tax Assets	-	92.28	36.83	11.56	-	-
Other Long-Term Assets	-	366.84	567.17	412.83	534.73	576.15
Total Assets	-	19,367	15,335	12,723	11,021	8,171
Accounts Payable	-	688.98	589.25	534.02	428.13	424.6
Accrued Expenses	-	62.26	211.61	215.39	198.95	155.66
Short-Term Debt	-	-	695.36	669.45	876.6	703.33
Current Portion of Long-Term Debt	-	1,429	307.57	294.93	161.2	67.35
Current Portion of Leases	-	203.45	141.61	77.34	26.48	4.54
Current Income Taxes Payable	-	51.8	14.91	-	-	99.71
Current Unearned Revenue	-	-	104.03	322.14	87	74.07
Other Current Liabilities	-	430.73	109.84	95.46	123.86	91.84
Total Current Liabilities	-	2,866	2,174	2,209	1,902	1,621
Long-Term Debt	-	106.07	184.07	474.09	410.54	142.06
Long-Term Leases	-	570.87	334.84	182.77	158.68	8.27
Long-Term Unearned Revenue	-	126.79	53.21	11.5	14.21	12.54
Long-Term Deferred Tax Liabilities	-	578.92	414.36	301.1	327.45	293.24
Other Long-Term Liabilities	-	280.65	-	-	-	-
Total Liabilities	-	4,561	3,174	3,180	2,814	2,096
Common Stock	-	250.59	250.38	249.51	249.51	243.13
Additional Paid-In Capital	-	-	3,511	3,385	3,385	2,044
Retained Earnings	-	-	8,368	5,795	4,465	3,741
Comprehensive Income & Other	-	13,581	53.84	127.23	108.18	29.2
Total Common Equity	13,832	13,832	12,184	9,556	8,208	6,057
Minority Interest	-	974.09	-22.23	-13.71	-0.68	18.39
Shareholders' Equity	14,806	14,806	12,161	9,543	8,207	6,075
Total Liabilities & Equity	-	19,367	15,335	12,723	11,021	8,171
Total Debt	2,309	2,309	1,663	1,699	1,633	925.55
Net Cash (Debt)	241.02	241.02	-302.7	-245.58	-369.23	11.53
Net Cash Growth	118.24%	-	-	-	-	-95.34%
Net Cash Per Share	0.96	0.96	-1.21	-0.98	-1.49	0.05
Filing Date Shares Outstanding	250.61	250.35	250.38	249.51	249.51	249.51
Total Common Shares Outstanding	250.61	250.35	250.38	249.51	249.51	243.13
Working Capital	-	4,586	2,788	1,980	1,523	736.75
Book Value Per Share	55.25	55.25	48.66	38.30	32.89	24.91
Tangible Book Value	12,900	12,900	12,133	9,548	8,196	6,038
Tangible Book Value Per Share	51.53	51.53	48.46	38.27	32.85	24.83
Land	-	-	43.41	43.41	43.41	32.26
Buildings	-	-	2,693	2,295	1,620	1,501
Machinery	-	-	6,992	5,673	4,808	3,948
Construction In Progress	-	-	123.25	697.07	494.44	360.77
Leasehold Improvements	-	-	138.16	132.51	72.76	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.